Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02898 (Long intergenic non-protein coding RNA 2898; C2orf91) is annotated as a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs (lncRNAs) generally defined as RNA transcripts longer than 200 nucleotides that do not overlap or encode for known protein-coding genes. LINC02898 is currently categorized as "putative" and "uncharacterized," with no experimentally confirmed protein product or established biological function. While lincRNAs as a class are known to participate in diverse gene regulation processes—such as remodeling chromatin, regulating transcription, stabilizing RNAs, or scaffolding regulatory proteins—no such specific roles have been demonstrated for LINC02898. There is no evidence that LINC02898 is a drug target, biomarker, or has a defined association with any disease state at present. Key Notes: - LINC02898 is not a receptor, enzyme, transporter, or recognized therapeutic target. - Its status as "putative uncharacterized protein" is likely a reflection of automated gene annotation pipelines, not functional evidence. - As with many lincRNAs, its function, disease associations, and potential as a biomarker or target remain unelucidated. If you are seeking structured information for database curation or target validation workflows, LINC02898 should be categorized as a non-protein-coding, uncharacterized lincRNA, not a known druggable target.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2898 (LINC02898).